NICE recommends new psoriasis treatment
The National Institute for Health and Care Excellence has issued final draft guidance recommending a new treatment for psoriasis. Secukinumab (Cosentyx; Novartis) is recommended as an option for treating some adults with plaque psoriasis if they are unable to take standard systemic therapies and if the drug is provided with the agreed patient access scheme discount.
Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2015.20068636
Recommended from Pharmaceutical Press